Jan Paul de Boer

Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer.

F. Hoebers, C. Terhaard, M. Heymans, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer.

J. Becker, J. Bourhis, F. Ciardiello, 2021, Cancer treatment reviews.

Role of chemotherapy in gastric MALT lymphoma, diffuse large B-cell lymphoma and other lymphomas.

M. Raderer, Jan Paul de Boer, 2010, Best practice & research. Clinical gastroenterology.

Total laryngectomy for a dysfunctional larynx after (chemo)radiotherapy.

F. Hilgers, O. Hamming-Vrieze, M. W. van den Brekel, 2012, Archives of otolaryngology--head & neck surgery.

A predictive model for residual disease after (chemo) radiotherapy in oropharyngeal carcinoma: Combined radiological and clinical evaluation of tumor response

J. Sonke, B. Jasperse, A. Al-Mamgani, 2017, Clinical and translational radiation oncology.

Baseline peripheral blood leukocytosis: Biological marker predicts outcome in oropharyngeal cancer, regardless of HPV-status.

J. Sonke, A. Al-Mamgani, A. Navran, 2018, Oral oncology.